X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125545
https://www.patentdocs.org/2019/12/amgen-inc-v-hospira-inc-fed-cir-2019.html
https://www.bigmoleculewatch.com/2019/12/16/breaking-news-federal-circuit-affirms-amgens-70-million-damages-award-against-pfizer-unit/
https://endpts.com/the-top-10-franchise-drugs-in-biopharma-history-will-earn-a-total-of-1-4t-trillion-by-2024-what-does-that-tell-us/
http://www.pmlive.com/pharma_news/az_preps_new_roxadustat_filings,_though_data_foxes_investors_1287583
https://www.fiercebiotech.com/biotech/fibrogen-sinks-as-roxadustat-safety-results-confuse-investors
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125545
https://www.biopharmadive.com/news/pfizer-launches-biosimilar-version-of-amgens-epogen/542282/
https://www.ema.europa.eu/documents/overview/binocrit-epar-medicine-overview_en.pdf
https://www.ema.europa.eu/documents/overview/abseamed-epar-medicine-overview_en.pdf
https://www.ema.europa.eu/documents/overview/abseamed-epar-medicine-overview_en.pdf
https://www.ema.europa.eu/documents/overview/epoetin-alfa-hexal-epar-summary-public_en-0.pdf
https://www.biospace.com/article/releases/pfizer-s-retacrit-the-first-erythropoietin-stimulating-agent-to-be-fda-approved-not-likely-to-see-rapid-adoption-in-the-us-dialysis-market/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103234
https://www.fiercepharma.com/pharma/amgen-s-neulasta-to-face-u-s-biosim-competition-coming-weeks-mylan-approval
http://www.biosimilarsip.com/2018/05/22/litigation-spotlight-update-epogen-litigation-status-in-face-of-retacrit-regulatory-approval/
https://www.reuters.com/article/us-pfizer-fda/pfizers-biosimilar-of-amgen-jjs-anemia-treatments-gets-fda-nod-idUSKCN1IG2Q0
https://endpts.com/pfizer-finally-finishes-a-3-year-regulatory-odyssey-bagging-an-fda-ok-for-1st-epogen-knockoff/
https://www.raps.org/news-and-articles/news-articles/2018/5/pfizers-epoetin-alfa-biosimilar-approved-by-fda?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=xpsS4
https://www.biospace.com/article/kirin-cashes-out-of-amgen-drug-joint-venture-for-780m/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-27-2017-1506575777.pdf
Market Place
Share 
